Eupraxia Pharmaceuticals (EPRX) EPS (Diluted) (2023 - 2026)
Eupraxia Pharmaceuticals' EPS (Diluted) was -$0.36 in the quarter ended Jun 30, 2026, compared with -$0.26 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) EPS (Diluted) (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eupraxia Pharmaceuticals' EPS (Diluted) was -$1.26 through Jun 30, 2026; for the year ended Dec 31, 2025, it was -$0.97.
- In earlier years, EPS (Diluted) was -$0.76 in the year ended Dec 31, 2024, -$1.20 in the year ended Dec 31, 2023 and -$0.98 in the year ended Dec 31, 2022.
- Quarterly EPS (Diluted) has moved between -$0.49 (the quarter ended Jun 30, 2023) and -$0.19 (the quarter ended Sep 30, 2025) over five years.
- Per Business Quant data, EPRX's EPS (Diluted) in the three quarters before the quarter ended Jun 30, 2026 was -$0.32 (quarter ended Mar 31, 2026), -$0.42 (quarter ended Dec 31, 2025) and -$0.19 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.31 |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - | -0.36 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.36 |
| Mar 31, 2026 | -0.32 |
| Dec 31, 2025 | -0.42 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.26 |
| Mar 31, 2025 | -0.20 |
| Dec 31, 2024 | -0.22 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -0.25 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.21 |
API Access
Eupraxia Pharmaceuticals EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();